194 related articles for article (PubMed ID: 25677806)
1. RhoC and ROCKs regulate cancer cell interactions with endothelial cells.
Reymond N; Im JH; Garg R; Cox S; Soyer M; Riou P; Colomba A; Muschel RJ; Ridley AJ
Mol Oncol; 2015 Jun; 9(6):1043-55. PubMed ID: 25677806
[TBL] [Abstract][Full Text] [Related]
2. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
[TBL] [Abstract][Full Text] [Related]
3. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
Chen R; Cheng Y; Zhang Y; Li Z; Geng L
Int J Gynecol Cancer; 2014 Feb; 24(2):184-91. PubMed ID: 24457551
[TBL] [Abstract][Full Text] [Related]
4. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets.
Vega FM; Fruhwirth G; Ng T; Ridley AJ
J Cell Biol; 2011 May; 193(4):655-65. PubMed ID: 21576392
[TBL] [Abstract][Full Text] [Related]
5. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
7. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma.
Jiang L; Liu X; Kolokythas A; Yu J; Wang A; Heidbreder CE; Shi F; Zhou X
Int J Cancer; 2010 Aug; 127(3):505-12. PubMed ID: 20232393
[TBL] [Abstract][Full Text] [Related]
9. RhoA, RhoB and RhoC have different roles in cancer cell migration.
Ridley AJ
J Microsc; 2013 Sep; 251(3):242-9. PubMed ID: 23488932
[TBL] [Abstract][Full Text] [Related]
10. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.
Giang Ho TT; Stultiens A; Dubail J; Lapière CM; Nusgens BV; Colige AC; Deroanne CF
Mol Biol Cell; 2011 Sep; 22(17):3263-75. PubMed ID: 21757538
[TBL] [Abstract][Full Text] [Related]
11. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
[TBL] [Abstract][Full Text] [Related]
12. RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells.
Hoeppner LH; Sinha S; Wang Y; Bhattacharya R; Dutta S; Gong X; Bedell VM; Suresh S; Chun C; Ramchandran R; Ekker SC; Mukhopadhyay D
J Cell Sci; 2015 Oct; 128(19):3556-68. PubMed ID: 26136364
[TBL] [Abstract][Full Text] [Related]
13. RhoBTB1 interacts with ROCKs and inhibits invasion.
Haga RB; Garg R; Collu F; Borda D'Agua B; Menéndez ST; Colomba A; Fraternali F; Ridley AJ
Biochem J; 2019 Sep; 476(17):2499-2514. PubMed ID: 31431478
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
15. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S
J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of Rho GTPase signaling.
Croft DR; Olson MF
Transcription; 2011; 2(5):211-5. PubMed ID: 22231116
[TBL] [Abstract][Full Text] [Related]
17. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
[TBL] [Abstract][Full Text] [Related]
18. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
19. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
20. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
